- Home
- ESCA vs FBRX Comparison
ESCA vs FBRX Comparison
Compare ESCA & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESCA
- FBRX
- Stock Information
- Founded
- ESCA 1922
- FBRX N/A
- Country
- ESCA United States
- FBRX United States
- Employees
- ESCA N/A
- FBRX N/A
- Industry
- ESCA Recreational Games/Products/Toys
- FBRX Biotechnology: Pharmaceutical Preparations
- Sector
- ESCA Consumer Discretionary
- FBRX Health Care
- Exchange
- ESCA Nasdaq
- FBRX Nasdaq
- Market Cap
- ESCA 159.4M
- FBRX 154.5M
- IPO Year
- ESCA N/A
- FBRX N/A
- Fundamental
- Price
- ESCA $11.80
- FBRX $12.12
- Analyst Decision
- ESCA
- FBRX Strong Buy
- Analyst Count
- ESCA 0
- FBRX 3
- Target Price
- ESCA N/A
- FBRX $68.00
- AVG Volume (30 Days)
- ESCA 17.4K
- FBRX 95.4K
- Earning Date
- ESCA 10-27-2025
- FBRX 11-13-2025
- Dividend Yield
- ESCA 5.04%
- FBRX N/A
- EPS Growth
- ESCA 10.02
- FBRX N/A
- EPS
- ESCA 0.92
- FBRX N/A
- Revenue
- ESCA $241,492,000.00
- FBRX N/A
- Revenue This Year
- ESCA N/A
- FBRX N/A
- Revenue Next Year
- ESCA N/A
- FBRX N/A
- P/E Ratio
- ESCA $12.91
- FBRX N/A
- Revenue Growth
- ESCA N/A
- FBRX N/A
- 52 Week Low
- ESCA $11.55
- FBRX $4.11
- 52 Week High
- ESCA $16.99
- FBRX $28.68
- Technical
- Relative Strength Index (RSI)
- ESCA 41.54
- FBRX 42.40
- Support Level
- ESCA $11.69
- FBRX $13.76
- Resistance Level
- ESCA $12.15
- FBRX $14.99
- Average True Range (ATR)
- ESCA 0.40
- FBRX 1.20
- MACD
- ESCA -0.04
- FBRX -0.40
- Stochastic Oscillator
- ESCA 15.41
- FBRX 9.87
About ESCA Escalade Incorporated
Escalade Inc manufactures and distributes sporting goods for a varied range of activities. These sports include archery, table tennis, basketball goals, trampoline, play systems, fitness, game tables like hockey and soccer, billiards, darting and other outdoor games. These products are sold under the brand names like Goalrilla, Goalsetter, Woodplay, Silverback, Nodor, Rage, Child Life, among others. The geographic segments in which the company operates are North America, Europe and others out of which a substantial part of the revenue is generated from North America region.
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).